These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8297148)

  • 21. Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats.
    Reinhardt M; Heyl P; Amelung F; Berger MR
    Arzneimittelforschung; 1992 Oct; 42(10):1239-42. PubMed ID: 1282010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats.
    Formelli F; Zaccheo T; Casazza AM; Bellini O; Di Marco A
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1211-21. PubMed ID: 6460631
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
    Mohammed SI; Bennett PF; Craig BA; Glickman NW; Mutsaers AJ; Snyder PW; Widmer WR; DeGortari AE; Bonney PL; Knapp DW
    Cancer Res; 2002 Jan; 62(2):356-8. PubMed ID: 11809678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed.
    Khandaker MH; Kadhim SA; Ichim TE; Howson-Jan K; Chin J; Singhal SK
    Anticancer Res; 2000; 20(1A):183-9. PubMed ID: 10769653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate.
    Kemberling JK; Hampton JA; Keck RW; Gomez MA; Selman SH
    J Urol; 2003 Sep; 170(3):773-6. PubMed ID: 12913695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New developments in first- and second-line chemotherapy for transitional cell, squamous cell and adenocarcinoma of the bladder.
    De Santis M; Bachner M
    Curr Opin Urol; 2007 Sep; 17(5):363-8. PubMed ID: 17762632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption.
    Alvarez E; Westmore M; Galvin RJ; Clapp CL; Considine EL; Smith SJ; Keyes K; Iversen PW; Delafuente DM; Sulaimon S; Zambrano C; Ma L; Sato M; Martin TJ; Teicher BA; Galbreath EJ
    Clin Cancer Res; 2003 Nov; 9(15):5705-13. PubMed ID: 14654555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Morphological and histochemical study of certain tumors of the bladder].
    Bialik VL; Romanenko AM
    Arkh Patol; 1972; 34(5):22-8. PubMed ID: 4668549
    [No Abstract]   [Full Text] [Related]  

  • 29. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.
    Cohen LA; Marks PA; Rifkind RA; Amin S; Desai D; Pittman B; Richon VM
    Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purinergic receptor-mediated effects of ATP in high-grade bladder cancer.
    Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
    BJU Int; 2008 Jan; 101(1):106-12. PubMed ID: 17941929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer.
    Le Visage C; Rioux-Leclercq N; Haller M; Breton P; Malavaud B; Leong K
    J Urol; 2004 Mar; 171(3):1324-9. PubMed ID: 14767342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide.
    Dinney CP; Parker C; Dong Z; Fan D; Eve BY; Bucana C; Radinsky R
    Clin Cancer Res; 1997 Feb; 3(2):161-8. PubMed ID: 9815668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. I. Biological studies.
    Benrezzak O; Madarnas P; Pageau R; Nigam VN; Elhilali MM
    Anticancer Res; 1989; 9(6):1883-7. PubMed ID: 2627134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion.
    Fujiyama C; Jones A; Fuggle S; Bicknell R; Cranston D; Harris AL
    Br J Cancer; 2001 Feb; 84(4):558-64. PubMed ID: 11207054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
    Derycke AS; Kamuhabwa A; Gijsens A; Roskams T; De Vos D; Kasran A; Huwyler J; Missiaen L; de Witte PA
    J Natl Cancer Inst; 2004 Nov; 96(21):1620-30. PubMed ID: 15523091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro and in vivo evaluation of inhibitory nucleic acid constructs for specific therapy of human urinary bladder carcinoma].
    Kunze D; Füssel S; Meye A; Wuttig D; Krämer K; Kotzsch M; Toma M; Schwenzer B; Kausch I; Jocham D; Hakenberg OW; Grimm MO; Wirth MP
    Urologe A; 2007 Sep; 46(9):1289. PubMed ID: 17665160
    [No Abstract]   [Full Text] [Related]  

  • 39. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.